Systematic review / meta-analysis / 2020
Low circulating phylloquinone was associated with higher all-cause mortality risk, but not CVD risk, in US adults.
Researchers conducted a participant-level meta-analysis of three US cohorts (Health ABC, MESA, and Framingham Offspring) to evaluate circulating phylloquinone (vitamin K-1) categories (≤0.5, >0.5-1.0, and >1.0 nmol/L) in relation to CVD and mortality over a median of 13.0 years. Among 3,891 participants, 858 incident CVD events and 1,209 deaths occurred. CVD risk did not significantly differ by phylloquinone status (fully adjusted HR 1.12, 95% CI: 0.94, 1.33 for ≤0.5 nmol/L vs. >1.0 nmol/L). However, participants with ≤0.5 nmol/L had a 19% higher risk of all-cause mortality compared with those with >1.0 nmol/L (fully adjusted HR 1.19, 95% CI: 1.03, 1.38).
Shows an association, not proof of cause and effect.
- Study type
- Participant-level meta-analysis of 3 prospective cohort studies
- Who was studied
- 3,891 participants from 3 US cohorts (mean age 65 ± 11 years; 55% women; 35% nonwhite)
- What was measured
- Incident cardiovascular disease (CVD) events and all-cause mortality
THE PAPER
Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts.
Shea MK, Barger K, Booth SL, Matuszek G, Cushman M, Benjamin EJ, Kritchevsky SB, Weiner DE. Am J Clin Nutr, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.